Search results for "030203 arthritis & rheumatology"

showing 10 items of 355 documents

Efecto del condroitín sulfato en la sinovitis de pacientes con artrosis de rodilla

2017

Resumen Objetivo Evaluar mediante ecografia el efecto del condroitin sulfato (CS) en la sinovitis de pacientes con artrosis (OA) de rodilla, y colaborar en el conocimiento de los mecanismos bioquimicos involucrados en la inflamacion sinovial. Metodos Estudio controlado, aleatorizado, ciego simple de 70 pacientes con OA de rodilla tratados durante 6 meses con CS o paracetamol (PCT). Los pacientes fueron visitados a tiempo basal, a las 6 semanas, y a los 3 y 6 meses para valorar el estado de su OA segun los siguientes parametros: sinovitis evaluada mediante ecografia (segun definicion de expertos OMERACT); dolor y funcion, mediante la escala visual analogica y el indice de Lequesne; y concent…

030203 arthritis & rheumatology0301 basic medicineGynecologyBioquímica03 medical and health sciencesmedicine.medical_specialty030104 developmental biology0302 clinical medicinebusiness.industrymedicineGeneral MedicinebusinessReumatología
researchProduct

New insights into the pathogenesis of giant cell arteritis

2017

Giant cell arteritis (GCA) is an inflammatory chronic disease occurring exclusively in elderly individuals. Until recently, the disease has been considered a unique disease resulting from the interaction in the walls of susceptible arteries, between an unknown infectious agents with local dendritic cells (DCs), activated CD4 T cells and effector macrophages. Recent evidence has shown that this view was too simplistic and has clarified many of the pathogenetic aspects of the disease. Many genetic studies recently published have identified different new genes, including cytokines, adhesion molecules and regulators of innate immunity, as crucial players in the development and progression of GC…

030203 arthritis & rheumatology0301 basic medicineImmunology and Allergy; ImmunologyInnate immune systemGiant Cell ArteritisImmunologyContext (language use)DiseaseBiologymedicine.diseasePathogenesisSettore MED/16 - Reumatologia03 medical and health sciencesGiant cell arteritis030104 developmental biology0302 clinical medicineImmune systemLymphatic systemAntigenImmunologymedicineAnimalsHumansImmunology and Allergyskin and connective tissue diseases
researchProduct

AB1209 THE RHEUMA-BUS-TOUR: TWO WEEK OPEN-ACCESS SCREENING FOR EARLY RHEUMATIC DISEASES

2019

Background Early diagnosis is crucial for patients with rheumatic diseases. Studies show that early stage patients already show reduced mental and physical health [2, 3]. However, early diagnosis is often delayed due to the severe lack of rheumatologists in Germany. Objectives The cross-sectional study compares data on physical and mental health of known and suspected early rheumatic patients, collected from participants of the bus tour. Methods The Rheuma-Bus-Tour is an annual, two week open-access screening event in three states (Rhineland-Palatine, Saarland, Lower Saxony) that raises awareness for rheumatic diseases and identifies people with potential early cases of RA, SpA and PsA. All…

030203 arthritis & rheumatology0301 basic medicinePediatricsmedicine.medical_specialtybusiness.industryPhysical functionMental healthTest (assessment)Screening questionnairePatient Health Questionnaire03 medical and health sciences030104 developmental biology0302 clinical medicineQuality of lifeEpidemiologymedicineFunctional abilitybusinessAbstracts Accepted for Publication
researchProduct

Physiopathologie des vascularites primitives des gros vaisseaux

2016

Giant cell arteritis (GCA) and Takayasu's arteritis (TA) are two granulomatous vasculitis affecting large arteries that present specific epidemiological and clinical features. Their pathogenesis is not fully understood but major advances have been obtained during the last years, thus allowing the emergence of new therapeutic strategies. GCA and TA develop on a specific genetic background but share some similarities regarding the immunological pathways involved in their pathogenesis. The trigger of these diseases is not clearly identified but it is thought that an infectious agent could activate and lead to the maturation of dendritic cells that are localized in the adventitia of arteries. T…

030203 arthritis & rheumatology0301 basic medicineTakayasu's arteritisGastroenterologyBiologymedicine.diseasePathogenesis03 medical and health sciencesGiant cell arteritis030104 developmental biology0302 clinical medicinemedicine.anatomical_structureImmune systemGiant cellAdventitiaImmunologyInternal MedicinemedicineCytotoxic T cellcardiovascular diseasesArteritisLa Revue de Médecine Interne
researchProduct

Reply

2017

030203 arthritis & rheumatology0301 basic medicinebusiness.industryImmunologymedicine.disease03 medical and health sciencesPsoriatic arthritis030104 developmental biology0302 clinical medicineImmune systemRheumatologyImmunologyImmunology and AllergyMedicineIn patientbusinessArthritis & Rheumatology
researchProduct

Research Article <i>CD40</i> rs4810485 <i>T>G</i> polymorphism and susceptibility to ankylosing spondylitis in the Latvian…

2018

Ankylosing spondylitis (AS) is a potentially disabling form of a systemic chronic inflammatory arthritis affecting mainly the axial skeleton, with or without extraspinal manifestations. The genetic basis of AS is partly known. Moreover, many autoimmunityrelated genes have pleiotropic effects. Multiple functional polymorphisms in the genes encoding the tumor necrosis factor (TNF) superfamily of cytokines, their receptors, and signaling proteins, are associated with susceptibility to autoimmune diseases. These arguments prompted us to conduct a study evaluating a possible association of single nucleotide polymorphism (SNP) rs4810485 of the CD40 gene, found previously to be involved in other i…

030203 arthritis & rheumatology0301 basic medicineeducation.field_of_studyAnkylosing spondylitisbusiness.industryInflammatory arthritisPopulationSingle-nucleotide polymorphismGeneral Medicinemedicine.diseaseMinor allele frequency03 medical and health sciences030104 developmental biology0302 clinical medicineGenotypeImmunologyGeneticsmedicineGene polymorphismAlleleeducationbusinessMolecular BiologyGenetics and Molecular Research
researchProduct

THU0569 MANAGEMENT OF ADULT-ONSET STILL’S DISEASE (AOSD) WITH IL-1 INHIBITORS: EVIDENCE- AND CONSENSUS-BASED STATEMENTS BY A PANEL OF ITALIAN EXPERTS

2019

Background: Still’s disease is a rare autoinflammatory disease, presenting in both pediatric [systemic juvenile idiopathic arthritis (SJIA)] and adult patients [adult-onset Still’s disease (AOSD]. Due to the rarity of the disease, clinical trials are limited and treatment guidelines are not available. In patients refractory to the classical therapy with NSAIDs, corticosteroids and DMARDs, the introduction of drugs targeting IL-1 has greatly expanded treatment options. Among these, canakinumab, a human monoclonal anti-IL-1β antibody, and anakinra, a human recombinant IL-1RA, have been recently approved for the treatment of refractory patients. Objectives: To produce recommendations, based on…

030203 arthritis & rheumatology0301 basic medicinemedicine.medical_specialtyAnakinraAdult-onset Still's diseaseAdult patientsbusiness.industryTreatment optionsBiologic treatmentClinical trial03 medical and health sciencesCanakinumab030104 developmental biology0302 clinical medicineFamily medicinemedicineIn patientbusinessmedicine.drugPoster Presentations
researchProduct

AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROM…

2019

Background: Seletalisib is a potent, selective oral inhibitor of phosphoinositide-3 kinase delta (PI3Kδ). Preclinical data have shown that the PI3Kδ pathway is upregulated within salivary glands of patients with PSS and contributes to disease pathogenesis.1 Objectives: To assess the efficacy and safety of seletalisib in patients with PSS. Methods: In this Phase II, double-blind, proof of concept study (NCT02610543), patients with PSS having an EULAR Sjogren’s Syndrome Disease Activity Index (ESSDAI) score ≥5 were randomised 1:1 to seletalisib once daily or placebo (PBO) in addition to current PSS therapy for 12 weeks. The primary endpoint was change from baseline in ESSDAI at Week 12. The s…

030203 arthritis & rheumatology0301 basic medicinemedicine.medical_specialtyLymphocytic infiltrationbusiness.industryPlaceboPreclinical dataDouble blind03 medical and health sciences030104 developmental biology0302 clinical medicineTolerabilitySeletalisibInternal medicinemedicineIn patientSjogren sbusiness
researchProduct

Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?

2016

030203 arthritis & rheumatology0301 basic medicinemedicine.medical_specialtyTumor Necrosis Factor-alphabusiness.industryImmunologic FactorsImmunogenicityGeneral MedicineRheumatologyDrug levelsAntirheumatic Agents03 medical and health sciences030104 developmental biology0302 clinical medicineAntirheumatic AgentsRheumatic DiseasesInternal medicineImmunologyHumansImmunologic FactorsMedicinePharmacology (medical)Anti-TNF therapyTumor necrosis factor alphabusinessExpert Opinion on Drug Safety
researchProduct

AB0691 INCREASED CARDIOVASCULAR RISK IN MIXED CONNECTIVE TISSUE DISEASE: EVALUATION OF MACROVASCULAR INVOLVEMENT AND ITS PREDICTORS BY AORTIC PULSE W…

2019

Background: Macrovascular involvement and cardiovascular (CV) risk have not been sufficiently studied in patients with mixed connective tissue disease (MCTD). In particular, the gold standard assessment method of aortic stiffness carotid-femoral pulse wave velocity (cfPWV) (1) has never been evaluated in patients with this disease. Objectives: Aims of the present study were to examine cfPWV in MCTD and to evaluate its associations with MCTD associated parameters and traditional CV risk factors. Methods: cfPWV measurements were performed in 43 MCTD patients and 107 healthy controls. The difference between cfPWV in the two groups was statistically examined and subsequently controlled for the …

030203 arthritis & rheumatology0301 basic medicinemedicine.medical_specialtybusiness.industryGold standardConfoundingmedicine.disease03 medical and health sciences030104 developmental biology0302 clinical medicineMixed connective tissue diseaseBlood pressureInternal medicineAssessment methodsmedicineCardiologyAortic stiffnessIn patientbusinessPulse wave velocityAbstracts accepted for Publication
researchProduct